Background Immunophenotyping and enumeration of plasma cells (PCs) by flow cytometry are deemed to be prognostically significant. However, PCs enumeration by flow cytometry is challenging owing to discrepancy with morphology and PCs loss during sample processing. Enumeration and differentiation of abnormal plasma cells (APCs) and normal plasma cells (NPCs) is difficult because abnormal antigen expression can be seen in subsets of NPCs. This is particularly true when a limited panel of antibodies are relied upon
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Bone marrow aspirates from 306 patients with multiple myeloma were analyzed by flow cytometric immun...
Background. Immunophenotyping by multiparameter flow cytometry (MFC) provides relevant information ...
A b s t r a c t We have developed a new statistical diagnostic model that examines the correlation b...
In recent years, several studies on large series of multiple myeloma (MM) patients have demonstrated...
The clinical relevance of flow cytometric immunopheno-typing (FCM) has been established in the diagn...
We have developed a new statistical diagnostic model that examines the correlation between immunophe...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Background and aim: The clinical impact of multiparametric flow cytometry (MFC) in multiple myeloma ...
Presence of normal plasma cells (PCs), hemodilution of bone marrow aspirate, and changes in the immu...
Background Multiple myeloma is an incurable disease characterized by proliferation of clonal maligna...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Background Multiple myeloma is an incurable disease characterized by proliferation of clonal maligna...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Bone marrow aspirates from 306 patients with multiple myeloma were analyzed by flow cytometric immun...
Background. Immunophenotyping by multiparameter flow cytometry (MFC) provides relevant information ...
A b s t r a c t We have developed a new statistical diagnostic model that examines the correlation b...
In recent years, several studies on large series of multiple myeloma (MM) patients have demonstrated...
The clinical relevance of flow cytometric immunopheno-typing (FCM) has been established in the diagn...
We have developed a new statistical diagnostic model that examines the correlation between immunophe...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Background and aim: The clinical impact of multiparametric flow cytometry (MFC) in multiple myeloma ...
Presence of normal plasma cells (PCs), hemodilution of bone marrow aspirate, and changes in the immu...
Background Multiple myeloma is an incurable disease characterized by proliferation of clonal maligna...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
Background Multiple myeloma is an incurable disease characterized by proliferation of clonal maligna...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identi...